Ambrx Biopharma (AMAM) Institutional Ownership

Notice: This company has been marked as potentially delisted and may not be actively trading.

Institutional Ownership Changes (13F Filings) for Ambrx Biopharma (NYSE:AMAM)

Current
Institutional Ownership
Percentage
77.28%
Number of
Institutional Buyers
(last 12 months)
27
Total
Institutional Inflows
(last 12 months)
$133.31M
Number of
Institutional Sellers
(last 12 months)
6
Total
Institutional Outflows
(last 12 months)
$90.67M
Get AMAM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Ambrx Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

AMAM Institutional Buying and Selling by Quarter

Ambrx Biopharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/26/2024Virtu Financial LLC20,386$290K0.0%N/A0.032%
2/26/2024Perceptive Advisors LLC78,811$1.12M0.0%N/A0.125%
2/22/2024Sierra Summit Advisors LLC37,237$530K0.2%N/A0.059%
2/15/2024Old Well Partners LLC14,400$205K0.2%N/A0.023%
2/15/2024Parkman Healthcare Partners LLC87,678$1.25M0.2%-41.5%0.139%
2/14/2024Altitude Crest Partners Inc.43,100$614K0.4%N/A0.068%
2/14/2024Lighthouse Investment Partners LLC88,925$1.27M0.1%N/A0.141%
2/13/2024Tower Research Capital LLC TRC5,614$80K0.0%+2,288.9%0.009%
2/12/2024Monashee Investment Management LLC207,500$2.96M0.5%+196.4%0.329%
2/12/2024TD Asset Management Inc140,256$2.00M0.0%+27.0%0.222%
2/6/2024WuXi AppTec Co. Ltd.1,000,000$14.24M36.9%N/A1.584%
1/31/2024Federated Hermes Inc.330,949$4.71M0.0%-86.2%0.524%
1/30/2024HealthInvest Partners AB57,847$824K0.7%N/A0.092%
1/24/2024China Universal Asset Management Co. Ltd.7,303$104K0.0%N/A0.012%
11/15/2023Alps Advisors Inc.45,531$524K0.0%+12.2%0.073%
11/14/2023Monashee Investment Management LLC70,000$805K0.3%N/A0.113%
11/13/2023Federated Hermes Inc.2,395,867$27.55M0.1%N/A3.864%
11/13/2023NWI Management LP160,935$1.85M0.1%N/A0.260%
11/13/2023FMR LLC1,761,058$20.25M0.0%-20.3%2.840%
11/9/2023Innovis Asset Management LLC31,137$358K0.1%+85.1%0.050%
10/27/2023TD Asset Management Inc110,456$1.27M0.0%+73.3%0.178%
10/24/2023Bank of New York Mellon Corp47,433$545K0.0%N/A0.076%
8/15/2023Silverarc Capital Management LLC100,000$1.65M0.5%N/A0.162%
8/15/2023HighVista Strategies LLC153,431$2.53M1.2%N/A0.248%
8/15/2023Commodore Capital LP3,175,000$52.26M5.9%-33.9%5.142%
8/14/2023Cormorant Asset Management LP9,616,155$158.28M8.9%+13.1%15.573%
8/11/2023VR Adviser LLC2,484,960$40.90M6.5%-24.7%4.499%
8/11/2023ExodusPoint Capital Management LP477,558$7.86M0.1%+2,349.4%0.865%
8/9/2023TD Asset Management Inc63,728$1.05M0.0%+358.5%0.115%
8/3/2023Innovis Asset Management LLC16,826$277K0.1%N/A0.030%
7/20/2023 Exchange Traded Concepts LLC9,830$162K0.0%N/A0.018%
7/13/2023QP Wealth Management LLC12,670$209K0.3%N/A0.023%
5/15/2023Commodore Capital LP4,803,447$42.85M6.5%N/A12.433%
5/15/2023Ghost Tree Capital LLC250,000$2.23M0.7%N/A0.647%
5/15/2023Farallon Capital Management LLC361,000$3.22M0.0%N/A0.934%
5/10/2023Tocqueville Asset Management L.P.12,500$112K0.0%N/A0.032%
5/9/2023Tower Research Capital LLC TRC20,440$182K0.0%+681,233.3%0.053%
4/28/2023Fosun International Ltd249,190$2.22M0.2%-87.1%0.645%
3/15/2023B. Riley Wealth Advisors Inc.20,000$45K0.0%N/A0.052%
2/14/2023Alpine Global Management LLC46,723$106K0.0%N/A0.121%
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.
11/14/2022Cormorant Asset Management LP2,336,389$2.52M0.2%-6.0%6.050%
5/16/2022Suvretta Capital Management LLC1,491,832$6.15M0.2%+41.0%3.866%
2/15/2022Adage Capital Partners GP L.L.C.1,923,700$17.37M0.0%+5.3%5.107%
2/14/2022Suvretta Capital Management LLC1,057,735$9.55M0.2%N/A2.808%
11/15/2021Tudor Investment Corp Et Al20,143$272K0.0%-66.4%0.053%
11/12/2021Ghisallo Capital Management LLC15,000$203K0.0%-62.5%0.040%
11/9/2021BlackRock Inc.820,221$11.07M0.0%-3.6%2.177%
8/25/2021Marshall Wace North America L.P.32,648$640K0.0%N/A0.087%
8/17/2021Millennium Management LLC144,092$2.82M0.0%N/A0.383%
8/17/2021Octagon Capital Advisors LP450,000$8.82M1.8%N/A1.195%
8/17/2021Boothbay Fund Management LLC13,422$263K0.0%N/A0.036%
8/17/2021Caas Capital Management LP40,000$784K0.0%N/A0.106%
8/16/2021Tudor Investment Corp Et Al60,000$1.18M0.0%N/A0.159%
8/13/2021FMR LLC3,766,940$68.73M0.0%N/A10.000%
8/12/2021Fosun International Ltd1,932,591$37.88M2.2%N/A5.130%
8/12/2021Monashee Investment Management LLC110,000$2.16M0.3%N/A0.292%
8/11/2021BlackRock Inc.850,676$16.67M0.0%N/A2.258%
7/30/2021Alliancebernstein L.P.70,000$1.37M0.0%N/A0.186%
(Data available from 1/1/2016 forward)

AMAM Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of AMAM shares?

During the previous two years, 34 institutional investors and hedge funds held shares of Ambrx Biopharma. The most heavily invested institutionals were Cormorant Asset Management LP ($158.28M), Commodore Capital LP ($52.26M), VR Adviser LLC ($40.90M), FMR LLC ($20.25M), WuXi AppTec Co. Ltd. ($14.24M), ExodusPoint Capital Management LP ($7.86M), and Suvretta Capital Management LLC ($6.15M).Learn more on AMAM's institutional investors.

What percentage of Ambrx Biopharma stock is owned by institutional investors?

77.28% of Ambrx Biopharma stock is owned by institutional investors. Learn more on AMAM's institutional investor holdings.

Which institutional investors have been buying Ambrx Biopharma stock?

Of the 30 institutional investors that purchased Ambrx Biopharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Commodore Capital LP ($4.80M), Federated Hermes Inc. ($2.40M), Cormorant Asset Management LP ($1.12M), WuXi AppTec Co. Ltd. ($1M), ExodusPoint Capital Management LP ($458.06K), Suvretta Capital Management LLC ($434.10K), and Farallon Capital Management LLC ($361K).

How much institutional buying is happening at Ambrx Biopharma?

Institutional investors have bought a total of 12,125,900 shares in the last 24 months. This purchase volume represents approximately $135.25M in transactions.

Which Ambrx Biopharma major shareholders have been selling company stock?

The following institutional investors have sold Ambrx Biopharma stock in the last 24 months: Federated Hermes Inc. ($2.06M), Fosun International Ltd ($1.68M), Commodore Capital LP ($1.63M), VR Adviser LLC ($813.62K), FMR LLC ($449.56K), Cormorant Asset Management LP ($150.00K), and Parkman Healthcare Partners LLC ($62.32K).

How much institutional selling is happening at Ambrx Biopharma?

Institutional investors have sold a total of 6,852,262 shares in the last 24 months. This volume of shares sold represents approximately $90.84M in transactions.


This page (NYSE:AMAM) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners